On July 10, WuXi AppTec rose 3.09% in regular trading, trading at HK$152.4/share, with turnover of HK$76.92 million, extending gains for a second consecutive session.

On the news front, Daiwa recently issued a research report significantly raising WuXi AppTec's target price from HK$138 to HK$190, maintaining a \"Buy\" rating and naming it one of the top picks in China's CXO sector. The broker noted the company's Q1 continuing operations revenue grew 39.4% year-over-year, with adjusted non-IFRS net profit surging 71.7%, both exceeding market expectations, primarily driven by small-molecule CDMO business contributions and increased project deliveries. Daiwa raised its adjusted net profit forecasts for this year and next by 13.5% and 21.3% respectively, expressing confidence in a potential upward revision to full-year guidance.

Additionally, Morgan Stanley recently raised its H-share target price to HK$168, reaffirming WuXi AppTec as its top pick, while JPMorgan increased its holdings by approximately 2.37 million shares at around HK$155.71 per share, reflecting continued institutional confidence in the company's growth trajectory.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)